In TOMORROW's GEN webinar, sponsored by Akoya Biosciences, our distinguished presenter Dr. Sizun Jiang will describe how his findings can be extended to understanding immune-tumor interactions for a better understanding of immunotherapy responses and strategies in cohort of cutaneous T cell lymphoma (CTCL). Additionally, we will hear from Dr. Niro Ramachandran, who has had his finger on the pulse of the spatial biology market since its inception.
In this GEN Live event, sponsoredby IsoPlexis, we are excited to be joined by Gregory Zuckerman, a journalist for the Wall Street Journal and author of the new book: A Shot to Save the World: The Inside Story of the Life-or-Death Race for a COVID-19 Vaccine, who will take us on a deep dive into the inside story behind vaccine development for the COVID-19 vaccines.
In this GEN webinar, sponsored by 10X Genomics, our distinguished guest speaker Dr. Rui Chen will discuss how his team at Baylor College of Medicine took on the complexity of gene expression and regulation in the human retina by generating a multiomic cell atlas at single-cell resolution.
Join us for this GEN webinar, sponsored by Thermo Fisher, where our expert panelists will take you through the downstream process of AAV purification and the characterization steps associated with process development and their application in manufacturing lot release testing.
This GEN webinar, sponsored by Unchained Labs, will show that whether a nanoparticle’s payload is RNA, DNA, protein, or another API, Big Tuna handles buffer exchange and concentration while Stunner delivers dye-free, label-free, standard-free, hassle-free quant.
From R&D through Process Development to Manufacturing, our CAR-T Connect virtual event offers a unique opportunity to interact with CAR-T therapy pioneers from start-ups to big pharma. This virtual event, sponsored by Sartorius, includes access to expert plenary presentations, lively Q&A and discussions, networking opportunities, and focused break-out sessions.
REGISTER NOW Broadcast Date: February 5, 2019Time: 8:00 am PT, 11:00 am ET, 17:00 CET Antibody-drug conjugates select ADCs) were initially developed to provide a selective targeting mechanism...
GEN's on demand webinar, sponsored by Dassault Systèmes, discusses the current state of The Living Brain Project and how it is being applied to traumatic brain injury, neuromodulation, neurodegenerative disease progression, and drug delivery through cerebrospinal fluid.
This presentation will show how low concentrated samples, as well as libraries prepared for long read sequencing benefit from QC, performed with the Femto Pulse.
While the importance of ligand-receptor binding kinetics on drug action is becoming well established, focus to date has been almost entirely on the role of the dissociation constant on drug efficacy and duration of action. The association rate constant, in contrast, has been largely overlooked, with many investigators still considering it diffusion-limited and equivalent across a compound series. This GEN webinar aims to remedy that by turning the spotlight onto the undervalued and oft-ignored association rate constant.
In this GEN webinar, we will hear from Danica Stanimirovic MD, PhD, and Danica Stanimirovic MD, PhD, wto leading scientists who will describe their current antibody engineering research projects and the therapeutic potential they hold.
In this GEN webinar sponsored by Advanced Cell Diagnostics, we will hear about new PDAC research showing that the cytokine leukemia inhibitory factor (LIF) key paracrine factor from activated pancreatic stellate cells acting on cancer cells.
In this GEN webinar, we will learn from Dr. Daniel Lauster, who, when faced with many of the challenges described above, utilized MicroScale Thermophoresis (MST) to measure the interaction between more than 100 novel non-toxic multivalent nanoparticle-conjugates and intact IAV in solution with as little as nanomoles of nanoparticles. Additionally, we will hear from Dr. Matthias Molnar how MST is becoming scientists’ first choice for the characterization of molecular interactions thanks to its flexible throughput, low sample consumption, and measurements in solution or in close to native conditions.
In this GEN webinar, we will hear about recent findings implicating the Hippo effector, Yap, as a driver of a novel damaged-induced intestinal stem cell population.
In this roundtable, our panelists will discuss assessing the validity of biomarkers to inform drug development and potential combination therapies. Key considerations include predictive testing of biomarkers, analytical methods, drug-diagnostic co-development and potential reimbursement considerations.
In this webinar, we will learn from Dr. Marcel Tigges about some of the production challenges faced by researchers working on large molecule process development. Additionally, we will hear from Dr. Silvia Würtenberger, on how Prometheus is the new gold standard that precisely characterizes protein stability by looking at thermal and chemical unfolding of proteins in a label-free way, using a tiny amount of sample.